Live Breaking News & Updates on Nonrelapse Mortality

Stay updated with breaking news from Nonrelapse mortality . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers

Encouraging data with RFS, OS, and NRM for Orca-T was also matched in a population of patients with hematologic cancers aged 55 years and older. ....

Novartis Pharmaceuticals Corporation , Bone Marrow Transplantation Stem Cell Processing Center , Astrazeneca Pharmaceuticals , Pfizer Inc , Seagen Inc , Jonsson Comprehensive Cancer Center , Jazz Pharmaceuticals , Arog Pharmaceuticals , University Of California Los Angeles , Cellular Therapy , California Los Angeles , Comprehensive Cancer Center , Orca Bio , Phase 1b Trial Nct04013685 , 2024 Transplantation Amp Cellular Therapy Meetings , Patients With Hematologic Cancers Aged 55 Years And Older , High Precision Cell Therapy Orcat , Relapse Free Survival , Overall Survival , Nonrelapse Mortality ,